FERD3L
Fer3-like protein
Also known as: bHLHa31, FER3L_HUMAN, N-TWIST, NATO3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96RJ6
- Gene
- FERD3L
- Ensembl
- ENSG00000146618
- Chromosome
- 7
- Canonical length
- 166 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in developmental process; negative regulation of DNA-templated transcription; and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including floor plate development; regulation of dopaminergic neuron differentiation; and regulation of neurogenesis. Predicted to be located in chromatin and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
166 residues, UniProt reviewed canonical sequence.
>Q96RJ6|FERD3L
1 MAAYPESCVD TTVLDFVADL SLASPRRPLL CDFAPGVSLG DPALALREGR PRRMARFEEG
61 DPEEEECEVD QGDGEEEEEE ERGRGVSLLG RPKRKRVITY AQRQAANIRE RKRMFNLNEA
121 FDQLRRKVPT FAYEKRLSRI ETLRLAIVYI SFMTELLESC EKKESGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FERD3L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 0.2 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 0.2 nTPM
- choroid plexus: 0.1 nTPM
- heart muscle: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- midbrain: 0.1 nTPM
- placenta: 0.1 nTPM
Single-cell type
- ependymal cells: 0.4 nCPM
- fibroblasts: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 13 nTPM
- pons: 5.6 nTPM
- cerebral cortex: 4.5 nTPM
- medulla oblongata: 2.9 nTPM
- white matter: 2.6 nTPM
- spinal cord: 2.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0.32
- gnomAD missense Z
- -0.4
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell development
- developmental process
- floor plate development
- negative regulation of DNA-templated transcription
- regulation of dopaminergic neuron differentiation
- regulation of neurogenesis
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- protein dimerization activity
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FERD3L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FERD3L as an antibody target. Whether an autoantibody or antibody against FERD3L could matter depends on whether native FERD3L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FERD3L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FERD3L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...